GlassScriptPhysician profile
Kristin Lee
NPI 1073856498
$21,173.84
in general payments reported to CMS, 2019-2025
10 companies · $21K in 2025
The $21K reported for 2025 was more than what 94% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2022: $52.53 · 2023: $287 · 2024: $80.28 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $1,750 · Food and Beverage: $707 · Education: $110 · Travel and Lodging: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,375.00 |
| Consulting Fee | $1,750.00 |
| Food and Beverage | $707.01 |
| Education | $109.64 |
| Travel and Lodging | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18,782.77 | 2022-2025 | |
| Janssen Biotech, INC. | $1,881.90 | 2023-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $140.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2023 | |
| Amgen INC. | $70.85 | 2025 | Otezla |
| Ucb, INC. | $62.36 | 2023 | Cimzia |
| Janssen Scientific Affairs, LLC | $49.21 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $48.37 | 2024 | Sotyktu |
| Galderma Laboratories, L.P. | $12.43 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.